🔎 Trials Near Me

Home › Obesity › NCT04997473

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

RecruitingHealthy volunteers welcome

Who can join

Ages 13 to 30 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study.
* Both male and female patients will be eligible.
* Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender.
* Patients must also be able to read English since the app intervention is only available in English form.

Exclusion Criteria:

* Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study.
* Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window.
* Patients whose BMI does not fall under the obese category will be excluded.
* No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.

About the study

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

What is being tested

Sponsor: University of California, Los Angeles · Participants: 20 · Started: Aug 15, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04997473

Locations in the U.S.

CaliforniaUCLA Mattel Children's Hospital, Los Angeles

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.